Plasmid-Based CRISPR-Cas9 Gene Editing in Multiple Candida Species

被引:2
|
作者
Lombardi, Lisa [1 ]
Oliveira-Pacheco, Joao [1 ]
Butler, Geraldine [1 ]
机构
[1] Univ Coll Dublin, Sch Biomol & Biomed Sci, Conway Inst, Dublin, Ireland
来源
MSPHERE | 2019年 / 4卷 / 02期
基金
爱尔兰科学基金会; 欧盟地平线“2020”;
关键词
CRISPR; Candida; genome; WEB TOOL; PARAPSILOSIS; PATHOGEN; DISRUPTION; CHOPCHOP; DELETION; ALBICANS;
D O I
10.1128/mSphere.00125-19
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Many Candida species that cause infection have diploid genomes and do not undergo classical meiosis. The application of clustered regularly interspaced short palindromic repeat-Cas9 (CRISPR-Cas9) gene editing systems has therefore greatly facilitated the generation of gene disruptions and the introduction of specific polymorphisms. However, CRISPR methods are not yet available for all Candida species. We describe here an adaption of a previously developed CRISPR system in Candida parapsilosis that uses an autonomously replicating plasmid. Guide RNAs can be introduced in a single cloning step and are released by cleavage between a tRNA and a ribozyme. The plasmid also contains CAS9 and a selectable nourseothricin SAT1 marker. It can be used for markerless editing in C. parapsilosis, C. orthopsilosis, and C. metapsilosis. We also show that CRISPR can easily be used to introduce molecular barcodes and to reintroduce wild-type sequences into edited strains. Heterozygous mutations can be generated, either by careful selection of the distance between the polymorphism and the Cas9 cut site or by providing two different repair templates at the same time. In addition, we have constructed a different autonomously replicating plasmid for CRISPR-Cas9 editing in Candida tropicalis. We show that editing can easily be carried out in multiple C. tropicalis isolates. Nonho-mologous end joining (NHEJ) repair occurs at a high level in C. metapsilosis and C. tropicalis. IMPORTANCE Candida species are a major cause of infection worldwide. The species associated with infection vary with geographical location and with patient population. Infection with Candida tropicalis is particularly common in South America and Asia, and Candida parapsilosis infections are more common in the very young. Molecular methods for manipulating the genomes of these species are still lacking. We describe a simple and efficient CRISPR-based gene editing system that can be applied in the C. parapsilosis species group, including the sister species Candida orthopsilosis and Candida metapsilosis. We have also constructed a separate system for gene editing in C. tropicalis.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Plasmid-Based CRISPR-Cas9 Gene Editing in Multiple Candida Species (vol 4, e00125-19, 2019)
    Lombardi, Lisa
    Oliveira-Pacheco, Joao
    Butler, Geraldine
    MSPHERE, 2020, 5 (03):
  • [2] Controlling CRISPR-Cas9 Gene Editing
    Dowdy, Steven F.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (03): : 289 - 290
  • [3] Introduction to CRISPR-Cas9 Gene Editing
    Mason, J. M.
    BIRTH DEFECTS RESEARCH, 2020, 112 (11): : 809 - 809
  • [4] Single-plasmid systems based on CRISPR-Cas9 for gene editing in Lactococcus lactis
    Song, Xin
    Liu, Lu
    Liu, Xin-Xin
    Xiong, Zhi-Qiang
    Xie, Chun-Liang
    Wang, Shij-Jie
    Ai, Lian-Zhong
    JOURNAL OF DAIRY SCIENCE, 2021, 104 (10) : 10576 - 10585
  • [5] A CRISPR-Cas9 system for multiple genome editing and pathway assembly in Candida tropicalis
    Zhang, Lihua
    Zhang, Haibing
    Liu, Yufei
    Zhou, Jingyu
    Shen, Wei
    Liu, Liming
    Li, Qi
    Chen, Xianzhong
    BIOTECHNOLOGY AND BIOENGINEERING, 2020, 117 (02) : 531 - 542
  • [6] Gene Editing of Human Hepatocytes by CRISPR-Cas9
    Zhang, Qingshuo
    Tiyaboonchai, Amita
    Balaji, Niveditha
    Naugler, Willscott
    Grompe, Markus
    MOLECULAR THERAPY, 2018, 26 (05) : 367 - 367
  • [7] CRISPR-cas9 Gene Editing for Cystic Fibrosis
    Xia, Emily
    MOLECULAR THERAPY, 2019, 27 (04) : 196 - 196
  • [8] CRISPR-Cas9 gene editing and human diseases
    Jinka, Chaitra
    Sainath, Chithirala
    Babu, Shyamaladevi
    Chakravarthi, Chennupati Ashok
    Prasanna, Muppidi Lakshmi
    Krishnan, Madhan
    Sekar, Gayathri
    Chinnaiyan, Mayilvanan
    Kumari, Andugula Swapna
    BIOINFORMATION, 2022, 18 (11) : 1081 - 1086
  • [9] CRISPR-Cas9 gene editing for patients with haemoglobinopathies
    不详
    LANCET HAEMATOLOGY, 2019, 6 (09): : E438 - E438
  • [10] In vivo Editing of the Human Mutant Rhodopsin Gene by Electroporation of Plasmid-based CRISPR/Cas9 in the Mouse Retina
    Latella, Maria Carmela
    Di Salvo, Maria Teresa
    Cocchiarella, Fabienne
    Benati, Daniela
    Grisendi, Giulia
    Comitato, Antonella
    Marigo, Valeria
    Recchia, Alessandra
    MOLECULAR THERAPY-NUCLEIC ACIDS, 2016, 5 : 1 - 12